Targeting specific areas in cancer cells improves treatment by increasing the precision of therapies. For example, therapies that target the HER2 pathway have been successful in treating certain types of breast cancer. These therapies work by interfering with the signaling pathways that promote cancer cell growth and survival. This targeted approach can lead to better outcomes and fewer side effects compared to chemotherapy, which affects both cancerous and healthy cells.
